Login / Signup

Trimethoprim/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model.

Maxwell J LaskoJennifer L Tabor-RennieYasmeen AbouelhassanJoseph L Kuti
Published in: The Journal of antimicrobial chemotherapy (2022)
In this in vitro chemostat model, trimethoprim/sulfamethoxazole monotherapy, even at higher doses, achieved limited activity against susceptible S. maltophilia.
Keyphrases
  • antibiotic resistance genes
  • clinical trial
  • combination therapy